BCL2 and cancer: This curcumin-evoked inhibition of NF-kB and the consequent suppression of E6 [21], leads to induction of p53, suppression of the NF-kB-Bcl-2 protective pathway, and preferential stimulation of the p53-Bax apoptotic pathway in cancer cells [19].